| Schedule Of Earnings Per Share, Basic And Diluted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
Six Months Ended
|
|
|
March 31,
|
|
March 31,
|
|
|
2021
|
|
2020
|
|
2021
|
|
2020
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (loss) income
|
$
|
(2,845,981)
|
|
$
|
(810,509)
|
|
$
|
14,381,720
|
|
$
|
(4,115,610)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic weighted average common shares outstanding
|
|
75,175,077
|
|
|
65,367,493
|
|
|
72,717,621
|
|
|
65,202,103
|
|
Net effect of dilutive instruments:
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock options
|
|
—
|
|
|
—
|
|
|
7,147,372
|
|
|
—
|
|
Stock appreciation rights
|
|
—
|
|
|
—
|
|
|
44,256
|
|
|
—
|
|
Common stock purchase warrants
|
|
—
|
|
|
—
|
|
|
744,821
|
|
|
—
|
|
Total net effect of dilutive instruments
|
|
—
|
|
|
—
|
|
|
7,936,449
|
|
|
—
|
|
Diluted weighted average common shares outstanding
|
|
75,175,077
|
|
|
65,367,493
|
|
|
80,654,070
|
|
|
65,202,103
|
|
Net (loss) income per basic common share outstanding
|
$
|
(0.04)
|
|
$
|
(0.01)
|
|
$
|
0.20
|
|
$
|
(0.06)
|
|
Net (loss) income per diluted common share outstanding
|
$
|
(0.04)
|
|
$
|
(0.01)
|
|
$
|
0.18
|
|
$
|
(0.06)
|
|